Baudson N - Search Results

1

The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.

Grignet-Debrus C, Cool V, Baudson N, Velu T, Calberg-Bacq CM. Grignet-Debrus C, et al. Among authors: baudson n. Cancer Gene Ther. 2000 Nov;7(11):1456-68. doi: 10.1038/sj.cgt.7700250. Cancer Gene Ther. 2000. PMID: 11129288

2

Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.

Grignet-Debrus C, Cool V, Baudson N, Degrève B, Balzarini J, De Leval L, Debrus S, Velu T, Calberg-Bacq CM. Grignet-Debrus C, et al. Among authors: baudson n. Cancer Gene Ther. 2000 Feb;7(2):215-23. doi: 10.1038/sj.cgt.7700108. Cancer Gene Ther. 2000. PMID: 10770629

3

Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells.

Gérard CM, Bruyns C, Delvaux A, Baudson N, Dargent JL, Goldman M, Velu T. Gérard CM, et al. Among authors: baudson n. Hum Gene Ther. 1996 Jan;7(1):23-31. doi: 10.1089/hum.1996.7.1-23. Hum Gene Ther. 1996. PMID: 8825865

4

Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma.

Cool V, Pirotte B, Gérard C, Dargent JL, Baudson N, Levivier M, Goldman S, Hildebrand J, Brotchi J, Velu T. Cool V, et al. Among authors: baudson n. Hum Gene Ther. 1996 Mar 20;7(5):627-35. doi: 10.1089/hum.1996.7.5-627. Hum Gene Ther. 1996. PMID: 8845388

5

Therapeutic potential of protein and adjuvant vaccinations on tumour growth.

Gérard CM, Baudson N, Kraemer K, Bruck C, Garçon N, Paterson Y, Pan ZK, Pardoll D. Gérard CM, et al. Among authors: baudson n. Vaccine. 2001 Mar 21;19(17-19):2583-9. doi: 10.1016/s0264-410x(00)00486-2. Vaccine. 2001. PMID: 11257396

6

Role and expression of CD40 on human retinal pigment epithelial cells.

Willermain F, Caspers-Velu L, Baudson N, Dubois C, Hamdane M, Willems F, Velu T, Bruyns C. Willermain F, et al. Among authors: baudson n. Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3485-91. Invest Ophthalmol Vis Sci. 2000. PMID: 11006243

7

Recombinant human papillomavirus type 16 E7 protein as a model antigen to study the vaccine potential in control and E7 transgenic mice.

Gérard CM, Baudson N, Kraemer K, Ledent C, Pardoll D, Bruck C. Gérard CM, et al. Among authors: baudson n. Clin Cancer Res. 2001 Mar;7(3 Suppl):838s-847s. Clin Cancer Res. 2001. PMID: 11300481

8

Nonclinical reproductive and developmental safety evaluation of the MAGE-A3 Cancer Immunotherapeutic, a therapeutic vaccine for cancer treatment.

Destexhe E, Stannard D, Wilby OK, Grosdidier E, Baudson N, Forster R, Gérard CM, Garçon N, Segal L. Destexhe E, et al. Among authors: baudson n. Reprod Toxicol. 2015 Jan;51:90-105. doi: 10.1016/j.reprotox.2014.12.009. Epub 2014 Dec 18. Reprod Toxicol. 2015. PMID: 25530039 Free article.

9

Tumor mouse model confirms MAGE-A3 cancer immunotherapeutic as an efficient inducer of long-lasting anti-tumoral responses.

Gérard C, Baudson N, Ory T, Louahed J. Gérard C, et al. Among authors: baudson n. PLoS One. 2014 May 15;9(5):e94883. doi: 10.1371/journal.pone.0094883. eCollection 2014. PLoS One. 2014. PMID: 24830315 Free PMC article.

10

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors.

Gérard C, Baudson N, Ory T, Segal L, Louahed J. Gérard C, et al. Among authors: baudson n. J Immunother. 2015 Oct;38(8):311-20. doi: 10.1097/CJI.0000000000000095. J Immunother. 2015. PMID: 26325375 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results